Klaudyna Fidyt

Nielubowicza 5 St
Warsaw, MZ 02097, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.

Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.

Journal: Leukemia

Published: March 11, 2026

mTORC1 inhibition upregulates CD20 and enhances anti-CD20 antibody efficacy in B-cell precursor acute lymphoblastic leukemia.

mTORC1 inhibition upregulates CD20 and enhances anti-CD20 antibody efficacy in B-cell precursor acute lymphoblastic leukemia.

Journal: Leukemia

Published: October 31, 2025

The costimulatory domain influences CD19 CAR-T cell resistance development in B-cell malignancies.

The costimulatory domain influences CD19 CAR-T cell resistance development in B-cell malignancies.

Journal: bioRxiv : the preprint server for biology

Published: March 17, 2025

CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia.

CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia.

Journal: Journal of hematology & oncology

Published: November 05, 2024

CAR-T cell therapy for cancer: current challenges and future directions.

CAR-T cell therapy for cancer: current challenges and future directions.

Journal: Signal transduction and targeted therapy

Published: October 07, 2024

LILRB1-directed CAR-T cells for the treatment of hematological malignancies.

LILRB1-directed CAR-T cells for the treatment of hematological malignancies.

Journal: Leukemia

Published: September 06, 2024

CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.

CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.

Journal: Oncoimmunology

Published: June 07, 2024

Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin.

Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin.

Journal: Cancer research

Published: March 04, 2024

Asciminib stands out as the superior tyrosine kinase inhibitor to combine with anti-CD20 monoclonal antibodies for the treatment of CD20+ Philadelphia-positive B-cell precursor acute lymphoblastic leukemia in preclinical models.

Asciminib stands out as the superior tyrosine kinase inhibitor to combine with anti-CD20 monoclonal antibodies for the treatment of CD20+ Philadelphia-positive B-cell precursor acute lymphoblastic leukemia in preclinical models.

Journal: Haematologica

Published: December 28, 2023

Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia-positive lymphoid leukemia to tyrosine kinase inhibitors.

Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia-positive lymphoid leukemia to tyrosine kinase inhibitors.

Journal: HemaSphere

Published: January 10, 2023

Efficient chimeric antigen receptor targeting of a central epitope of CD22.

Efficient chimeric antigen receptor targeting of a central epitope of CD22.

Journal: The Journal of biological chemistry

Published: November 17, 2022

CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies.

CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies.

Journal: Cells

Published: April 27, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026